Co-Moderated By: Tracy Valorie, Sr. VP & General Manager Pharmaceuticals Division – Bausch + Lomb Rose Wynne Brooks, Vice President Marketing – Carl Zeiss Meditec AG
9:15-9:20 – Eleven Biotherapeutics – Abbie C. Celniker, PhD, President & CEO 9:20-9:25 – Avedro – David Muller, PhD, President & CEO 9:25-9:30 – AcuFocus – Nick Tarantino, Chief Global Clinical Research & Regulatory Affairs Officer 9:30-9:35 – ReVision Optics – John T. Kilcoyne, President & CEO 9:35-9:40 – PowerVision – Barry Cheskin, President, CEO & Co-Founder 9:40-9:45 – Emmetrope – Andrew F. Phillips, MD, Founder, President & CEO 9:45-9:50 – Sharklet Technologies – Mark Spiecker, CEO 9:50-9:55 – ClearSight Innovations – Michael Mrochen, PhD, Co-Founder & CTO 9:55-10:00 – Mynosys - John Hendrick, President & CEO 10:00-10:05 – Jade Therapeutics - Arthur Klausner, MBA, CEO 10:05-10:10 – MicroOptx - Chris Pulling, CEO 10:10-10:15 – LacriScience - Chris Geddes, PhD, Chief Biomedical/Plasmonics Consultant
Company Presentations
Glaukos - Chris M. Calcaterra, Chief Commercial Officer
Ivantis - Dave Van Meter, President & CEO
Transcend Medical - Sean Ianchulev, MD, MPH, Chief Medical Officer & Vice President, Business Development
AqueSys - Ron Bache, President & CEO
Panel Discussion Moderated By: Eric D. Donnenfeld, MD, Clinical Professor, Ophthalmology - NYU
Market Overview Kuldev Singh, MD, MPH, Professor, Ophthalmology & Director, Glaucoma Service - Stanford University School of Medicine
Company Presentations
Aerie Pharmaceuticals - Thomas A. Mitro, President & COO
InnFocus - Russ Trenary, President & CEO
ForSight VISION5 - John Maroney, CEO
Panel Discussion Moderated By: Kuldev Singh, MD, MPH, Professor, Ophthalmology & Director, Glaucoma Service - Stanford University School of Medicine
Panel Participants: Thomas A. Mitro, President & COO - Aerie Pharmaceuticals Russ Trenary, President & CEO - InnFocus John Maroney, CEO - ForSight VISION5 John Berdahl, MD, Ophthalmologist - Vance Thompson Vision Jay Katz, MD, Director, Glaucoma Service - Wills Eye Hospital
12:05 pm
Networking Lunch Commences
Hosted By:
12:40 - 12:45 pm
Special Introduction
Special Introduction By: Calvin W. Roberts, MD, Sr. VP & Chief Medical Officer, Eye Care - Bausch + Lomb
Market Overview Richard L. Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
Panel Discussion Moderated By: Gilbert H. Kliman, MD, Managing Director - InterWest Partners
Panel Participants: Malvina B. Eydelman, MD, Director, Division of Ophthalmic and Ear, Nose & Throat Devices - FDA Jack T. Holladay, MD, MSEE, FACS, Clincal Professor of Ophthalmology - Baylor College of Medicine Calvin W. Roberts, MD, Sr. VP & Chief Medical Officer, Eye Care - Bausch + Lomb Laurent Attias, Head, Strategy, BD&L & Market Access - Alcon Jane E. Rady, Divisional Vice President, Business Development - Abbott Medical Optics
2:10 - 2:50 pm
Spotlight on Drug Delivery
Company Presentations
Envisia Therapeutics - Benjamin Yerxa, PhD, President & Co-Founder
Kala Pharmaceuticals - Charlie McDermott, Interim President & Chief Business Officer
Icon Bioscience - David S. Tierney, President & CEO
Ocular Therapeutix - Amarpreet Sawhney, PhD, President, CEO & Chairman of the Board
